Brucellosis is a challenging zoonosis to diagnose and treat. The recent outbreaks of Brucella abortus RB51 in several states in the United States, including New Jersey and Texas, due to raw milk consumption has raised the concern of drug-resistant Brucella spp. This commentary highlights the importance of being on the lookout for this emerging infection.
Patients with acute B. abortus RB51 infection present with fever, sweats, generalized fatigue and body aches. If not treated, they may develop long-term complications, e.g. hepato-splenomegaly, arthritis, myocarditis and, in rare cases, meningitis and/or orchitis. B. abortus RB51 can lead to miscarriages in pregnant women [1, 5, 6] .
It is important to identify which Brucella species is the disease causative agent for epidemiological and therapeutic purposes. Molecular testing plays a major role in the diagnosis of brucellosis [1, 4] . For instance, matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry was shown to be a reliable technique to identify the main human pathogenic Brucella spp, including B. melitensis, B. abortus, B. canis and B. suis [7] . Real-time polymerase chain reaction (PCR) is a decent tool for diagnosing Brucella spp. from human blood and serum specimens, with a specificity of 100 % and a sensitivity range from 79 % (for serum specimens) to 99.2 % (for wholeblood and serum specimens combined) [8] . Zerva et al demonstrated that serum was better than whole blood for diagnosing human brucellosis by PCR [9] . A PCR-based luminex bead-based suspension array showed promising results and high specificity in rapidly detecting eight species of Brucella in 3 to 4 h in dairy products [10] . Similarly, realtime PCR assays showed 100 % specificity while testing Brucella spp. from non-clinical specimens [11] . In addition to bacterial isolation, serological tests, e.g. the Brucella microagglutination test, can detect antibodies to B. abortus, B. melitensis or B. suis, but not B. canis and the B. abortus RB51 strain [12] .
Antimicrobial therapy should be started promptly once the diagnosis of brucellosis has been confirmed to prevent chronic infection. However, one should be aware that the B. abortus RB51 strain is resistant to rifampin, which should not be used for this particular infection [4] . Thus, if exposure to B. abortus RB51 is suspected, a 21-day course of doxycycline and trimethoprim/sulfamethoxazole is recommended as post-exposure prophylaxis [5, 6] .
In conclusion, B. abortus RB51 should be looked for if patients present with brucellosis symptoms and report the intake of unpasteurized dairy products to avoid long-term complications. Moreover, public awareness and counselling about the risk of brucellosis and raw milk intake are warranted to contain this life-threatening emerging infection.
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